Skip to content

Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children

A Randomized Controlled Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02697396
Enrollment
181
Registered
2016-03-03
Start date
2016-02-01
Completion date
2027-02-01
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Vaccination

Keywords

Social Marketing Campaign, Mexican American Children, 16-069

Brief summary

This project aims to raise awareness and improve HPV vaccination rates among children of Mexican American parents through the implementation of a tailored social marketing campaign which includes text messaging reminders.

Detailed description

This randomized controlled trial (RCT) will assess a social marketing campaign on HPV vaccination with and without a text messaging reminder system targeting Mexican Americans in a community-based setting, at the Ventanilla De Salud (Health Window, VDS) program and the Consulate on Wheels-Ventanilla De Salud Movil (Mobile Health Window, VDS on wheels) program of the Mexican Consulate. Investigators plan on recruiting 200 Mexican American parents of children ages 9 through 17. Every VDS attendee eligible for the study and who is willing to consent to participate will be invited to the study. Consenting participants will be randomized to either a follow-up reminder text messaging system or to the group which will not receive the text messaging reminders. All participants, regardless of text messaging arm, will evaluate the campaign and investigators will assess adherence to the HPV vaccine for the total sample.

Interventions

BEHAVIORALAssessments

All participants, after consent, will be asked to complete the study contact form and then complete a baseline assessment with the RSA. This baseline assessment will take approximately 5 minutes.

Participants randomly assigned to the text messaging group will receive a text message reminding them of their child's vaccination eligibility once a week, starting one week after exposure to the social marketing campaign and time of consent.

OTHERNo Text Messaging

Participants in this arm will receive no additional vaccination reminders.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER
The City College of New York
CollaboratorOTHER
Hackensack Meridian Health
CollaboratorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Born in Mexico or born in the U.S. but self-describes as Mexican-American Spanish is her/his primary language * Has a minimum of one child between the ages of 9 and 17 who has not received the HPV vaccine and who lives with the parent/guardian as per self report * Self-identifies as the child's main caregiver * Currently owns a cell phone, uses text messaging services and is willing to accept text messages for this study

Exclusion criteria

* Will not be in the NYC area for the duration of the study period (6-9 months) * Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who complete 3 doses of the HPV vaccine6 monthsThis study will determine the effect of a social marketing campaign on HPV vaccination targeting Mexican American parents or guardians of vaccine-eligible children comparing the campaign alone against the campaign plus text message reminders on the proportion of participants who complete 3 doses of the HPV vaccine for their youngest eligible child.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORFrancesca Gany, MD, MS

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026